Time to buy GILD. Dropped too far. Remesvidir
Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。